Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction — Tatjana Potpara (2018) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction
Shared by
Professor Gregory Lip
University of Liverpool
Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction
Article
2018
en
Authors
TP
Tatjana Potpara
CF
Charles J. Ferro
Professor Gregory Lip
University of Liverpool
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2018
Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction
Maria Mahmood
,
Professor Gregory Lip
Article
2023
Cardiac and renal outcomes of direct oral anticoagulants in patients with atrial fibrillation
Yuting Wang
,
Jo‐Hsin Chen
,
Shu‐Fen Liao
,
Yu‐Jen Chen
,
Professor Gregory Lip
,
Jong‐Shiuan Yeh
Article
2020
Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: A multicentre cohort study
Daniele Pastori
,
Evaristo Ettorre
,
Professor Gregory Lip
,
Angela Sciacqua
,
Francesco Perticone
,
Francesco Melillo
,
Cosmo Godino
,
Rossella Marcucci
,
Martina Berteotti
,
Francesco Violi
,
Pasquale Pignatelli
,
Mirella Saliola
,
Danilo Menichelli
,
Marco Casciaro
,
Vito Menafra
Article
2023
Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia
Chuan-Tsai Tsai
,
Yi‐Hsin Chan
,
Jo‐Nan Liao
,
Tzeng‐Ji Chen
,
Professor Gregory Lip
,
Shih-Ann Chen
,
Tze‐Fan Chao
Article
2023
Risk of incident atrial fibrillation and subsequent use of oral anticoagulants in patients with dementia
Tze‐Fan Chao
,
Ling Kuo
,
Professor Gregory Lip
,
S A Chen
Discussion(0)
No comments yet. Be the first to comment.